NIH-funded research NIH-funded research

Reprogramming the tumor-immune interface in oral cancer

Funded at Stanford University · NIH-11364966 · Data updated 2026-11-12

A Stanford-led project aims to help people with oral cancer by making the immune system better at recognizing and attacking tumor cells.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startSeptember 8, 2020
Project endJune 30, 2028
Funding year2026
Award (this year)$946,414
NIH project number5R35DE030054-07
Project IDNIH-11364966 on NIH RePORTER

Who could benefit from this research

Could help

Patients with oral squamous cell carcinoma, especially those whose disease may benefit from immune-based therapies.

Less likely to help

Patients whose tumors do not engage with immune-based strategies or who cannot tolerate immune therapies may see limited benefit.

What this research studies

This project studies how oral squamous cell carcinoma interacts with the immune system and tests strategies to make immune cells more effective against the cancer. Researchers use patient tumor samples and new mouse models to explore what makes tumors respond to immune signals, how to create targets for therapy, and how to boost natural killer cells to fight OSCC. The goal is to identify mechanisms that can be targeted to improve existing immunotherapies and develop new approaches for patients with oral cancer.

Why it matters

Potential benefit: If successful, this work could lead to more effective immunotherapies for oral cancer and higher survival rates.

How similar studies have gone: Previous research shows that the tumor-immune interface can be modulated to improve responses in some cancers, with ongoing exploration in OSCC.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Sunwoo, John B — Stanford University
  • Study coordinator: Sunwoo, John B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.